A West Lothian factory has been chosen to create over 60 million coronavirus vaccines by next year.
As part of a new £1.3 billion deal with the UK Government, the Valneva factory in Livingston will create and produce the potentially life saving drug.
Providing vaccine development is successful, the facility will begin working with the vaccine in December of this year.
If they are granted regulatory approval, the first doses could be registered by late 2021.
Over the next five years, the Lothian site will produce what is expected to be over 60 million vaccines next year alone, in the fight to stop the spread of COVID-19.
After this, Valneva will then create a further 40 million doses available in 2022 and 30 million to 90 million doses between 2023 and 2025.
The vaccine is expected to have a two-dose regimen.
Business Secretary Alok Sharma said: "Having visited Valneva just last month, I have seen first-hand the incredible work they are doing to develop and manufacture a COVID-19 vaccine.
To receive one WhatsApp message a day with Edinburgh Live's headlines, as well as breaking news alerts, text NEWS to 07899067815. Then add the number to your contacts as 'Edinburgh Live'.
"This new agreement could help us vaccinate millions of people across the country, as well as help create a UK vaccine manufacturing facility to speed up access to a potential COVID-19 candidate and boost the country's resilience against future pandemics."
Thomas Lingelbach, the CEO of Valneva, said: "We made the early decision to choose a proven and well-established inactivated vaccine approach which is further validated by this partnership.
"We are honoured to have been chosen by the UK Government and are eager to partner with them to address this terrible ongoing pandemic.
"This is another transformational step for Valneva following the Lyme partnership we signed earlier this year and our chikungunya vaccine commencing phase three clinical studies last week."
